UNSPSC 51142037: Bucetin

This classification denotes an analgesic agent with the molecular formula C12H17NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6M7CVQ8PF8, chemically known as p-butyrophenetidide, 3-hydroxy- but generally known as bucetin, which bears US NIH Compound Identifier 14130. European Medicines Agency schedules Bucetin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05942MIG. The term BUCETIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5).

UNSPSC 51142037 Bucetin, a Commodity code, does not reflect the actual work state and local governments are procuring under this classification. Recent opportunities posted to bucetin show solicitations for naloxone, generic pharmaceuticals, over-the-counter products, and pharmacy benefit program management—none of which are bucetin. The code appears to be a misclassification in state and local procurement systems, and the category shows little relevant recent activity aligned with its nominal definition.

State and local issuing bodies—Seminole County, Florida; the Texas Health and Human Services Commission; and the Minnesota Department of Administration's Office of State Procurement—have tagged naloxone procurement, direct-to-manufacturer prescription programs, and cooperative multi-source pharmaceutical sourcing to this code. The mismatch between the code's stated scope and the actual solicitations suggests that either the code has been incorrectly assigned to these opportunities or the taxonomy is not tracking pharmaceutical procurement accurately at this tier. Vendors should verify the correct UNSPSC coding before pursuing opportunities in this category, as the code does not reliably describe the pharmaceutical and naloxone-related work state and local governments are actually buying right now.